医学
肺结核
利福平
结核分枝杆菌
内科学
抗药性
耐多药结核病
结核病诊断
梅德林
病理
政治学
生物
微生物学
法学
作者
David Horné,Mikashmi Kohli,Jerry S. Zifodya,Ian Schiller,Nandini Dendukuri,Deanna Tollefson,Samuel G. Schumacher,Eleanor Ochodo,Madhukar Pai,Karen R Steingart
出处
期刊:The Cochrane library
[Elsevier]
日期:2019-06-07
卷期号:6: CD009593-CD009593
被引量:276
标识
DOI:10.1002/14651858.cd009593.pub4
摘要
We found Xpert MTB/RIF to be sensitive and specific for diagnosing PTB and rifampicin resistance, consistent with findings reported previously. Xpert MTB/RIF was more sensitive for tuberculosis in smear-positive than smear-negative participants and HIV-negative than HIV-positive participants. Compared with Xpert MTB/RIF, Xpert Ultra had higher sensitivity and lower specificity for tuberculosis and similar sensitivity and specificity for rifampicin resistance (1 study). Xpert MTB/RIF and Xpert Ultra provide accurate results and can allow rapid initiation of treatment for multidrug-resistant tuberculosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI